LATEST ALERTS
CBD products could be prescribed to British patients from as early as next month after the UK government announced plans to lift restrictions on the medical use of cannabis
A British health charity has warned people with epilepsy against using CBD products that do not have a pharmaceutical licence
Cannabis and nicotine together have notably different effects on the brain than either of them taken on their own. That’s the conclusion of US researchers who noted that cannabis is commonly consumed in conjunction with tobacco
A new series of animal studies purports to show that CBD is non-addictive – potentially clearing the way for further research into the mechanisms behind its possible beneficial qualities
Judicial bodies in France have issued statements clarifying the national legal framework for products containing cannabidiol (CBD) and asked local enforcement authorities to ensure compliance with current legislation
Synthetic cannabinoid products being sold in convenience stores and gas stations across the US are contaminated with an ingredient commonly found in rat poison, the US FDA says
US government agencies have questioned the legality of cannabidiol (CBD) – just as the industry is starting to benefit from increased public awareness
Cannabidiol (CBD) could be helpful in smoking cessation, but the area is little researched and more work is required, says a London scientist who will soon publish a paper on the topic
Vaping is reported to be one of the best ways to absorb CBD, a cannabinoid present in cannabis which has relaxing and pain-relieving effects but produces no psychoactive “high”. E-liquid containing CBD is already on the market
Enovap, an innovative French hardware manufacturer, has announced plans to move into the US market, where it hopes to apply its technology to medicinal cannabis use
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Get 7 days of access to industry updates through our news analysis and regulatory alerts
"*" indicates required fields
